Updates are available Correction dated 2021-03-29
Click to view Correction: https://doi.org/10.1007/s12072-021-10178-7
-
Authors
Cillo, Umberto
De Carlis, Luciano
Del Gaudio, Massimo
De Simone, Paolo
Fagiuoli, Stefano
Lupo, Francesco
Tisone, Giuseppe
Volpes, Riccardo
- License Information
-
More Information
Article History
Received: 13 May 2020
Accepted: 6 September 2020
First Online: 24 October 2020
Change Date: 29 March 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s12072-021-10178-7
Compliance with ethical standards
:
: Umberto Cillo declares that he has no conflict of interest. Luciano De Carlis declares that he has no conflict of interest. Massimo Del Gaudio declares that he has no conflict of interest. Paolo De Simone served as an advisory board member for Novartis, Astellas and Chiesi. Stefano Fagiuoli Advisory Board and Speaker’s Bureau for Abbvie, Gilead Sciences, MSD, Novartis, Astellas, Bayer, Kedrion, Intercept. Francesco Lupo served as advisory board member for Novartis, Astellas, Biotest, Chiesi. Giuseppe Tisone declares that he has no conflict of interest. Riccardo Volpes declares that he has no conflict of interest.
: This article does not contain any studies with human or animal subjects.
